Camlin Fine Sciences Limited (CFSL) has announced an adjustment to the timetable for its mandatory tender offer on Vinpai, a French société anonyme. This follows an earlier press release issued on November 28, 2025. The company has completed the acquisition of a majority stake in Vinpai, representing 78.68% of its share capital and 84.89% of voting rights, at a price of €3.60 per share on November 27, 2025. CFSL initially planned to file the simplified cash tender offer (OPAS) for the remaining Vinpai shares by mid-December 2025. However, due to time constraints in obtaining necessary Indian regulatory approvals for foreign investments, the filing has been postponed to the end of February 2026 at the latest. The company also reminded that if the minority shareholders' tendered shares do not exceed 10% of Vinpai's capital and voting rights, CFSL intends to request a mandatory squeeze-out procedure. Furthermore, the conversion of Vinpai's convertible bonds, leading to the issuance of 1,100,000 new ordinary shares to CFSL, is expected to occur by December 31, 2025. Following these events, CFSL will hold 83.82% of Vinpai’s share capital and 80.86% of its voting rights.